All In Biotech

Drug Trial Radar · NCT06159673

ACP-204 in Adults With Alzheimer's Disease Psychosis

A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease Psychosis

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,074 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,074

Planned (sponsor's estimate)

Start

Nov 14, 2023

Primary completion

Jan 2028

Study completion Feb 2028

Sponsor

Lead sponsor
ACADIA Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Dec 7, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 55 years, up to 95 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies in patients with ADP * Substudy 1 (Phase 2) will evaluate efficacy and dose response of ACP-204 30 and 60 mg vs placebo. This substudy will be initiated first. * Substudies 2A and 2B (both: Phase 3) will be confirmatory studies of either both doses (ACP-204 30 and 60 mg, respectively) or a single dose from Part 1 vs placebo. Substudies 2A and 2B will be performed independently of each other and will commence after enrollment of Part 1. All 3 substudies will be analyzed independently of each other. Each substudy individually will consist of a screening period (up to 49 days); a double-blind treatment period (6 weeks); a safety follow-up period (30 days) for patients not rolling over into an open-label extension study; and vital status follow-up (for patients who terminated their substudy early).

Conditions

  • Alzheimer's Disease Psychosis

Interventions

  • ACP-204Drug

    ACP-204 is a potent and selective antagonist/inverse agonist of 5-hydroxytryptamine (serotonin) receptor subtype 2A.

  • PlaceboDrug

    ACP-204 matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Scale for the Assessment of Positive Symptoms-Hallucinations and Delusions subscales (SAPS-H+D) total score change from baseline (Substudies 1, 2A, 2B)Time frame: From baseline to Week 6

Locations

155 sites in 12 countries. Site status is shown where the registry gives one.

  • Chandler Clinical Trials

    Chandler, Arizona · Withdrawn

  • Clinical Endpoint LLC

    Scottsdale, Arizona · Recruiting

  • Advanced Research Center, Inc.

    Anaheim, California · Withdrawn

  • ATP Clinical Research

    Costa Mesa, California · Recruiting

  • Neuro-Pain Medical Center

    Fresno, California · Recruiting

  • National Institute of Clinical Research

    Garden Grove, California · Terminated

  • Havana Research Institute LLC

    Pasadena, California · Recruiting

  • Quantum Clinical Research, Inc.

    Pasadena, California · Recruiting

  • Humanity Clinical Research Corp

    Aventura, Florida · Recruiting

  • Arrow Clinical Trials

    Daytona Beach, Florida · Recruiting

  • First Excellent Research Group

    Doral, Florida · Recruiting

  • New Life Medical Research Center Inc.

    Hialeah, Florida · Recruiting

  • Reliable Clinical Research LLC.

    Hialeah, Florida · Recruiting

  • Homestead Associates in Research Inc.

    Miami, Florida · Recruiting

  • Premier Clinical Research Institute, Inc.

    Miami, Florida · Recruiting

  • Central Miami Medical Institute

    Miami, Florida · Withdrawn

  • Advanced Clinical Research Network, Corp

    Miami, Florida · Recruiting

  • Verus Clinical Research

    Miami, Florida · Recruiting

  • Future Care Solution, LLC

    Miami, Florida · Recruiting

  • MediClear Medical & Research Center, Inc.

    Miami, Florida · Recruiting

  • ABBA Medical Group LLC

    Miami, Florida · Recruiting

  • Visionary Investigators Network

    Miami, Florida · Withdrawn

  • Quantum Clinical Trials

    Miami Beach, Florida · Recruiting

  • New Med Research

    Miami Gardens, Florida · Recruiting

  • Floridian Neuroscience Institutue

    Miami Lakes, Florida · Recruiting

  • Combined Research Orlando Phase I IV

    Orlando, Florida · Recruiting

  • Psych Me Medical Research Inc

    Tampa, Florida · Withdrawn

  • Neuroscience Research Institute

    West Palm Beach, Florida · Recruiting

  • Agile Clinical Research Trials LLC

    Atlanta, Georgia · Recruiting

  • Revive Research Institute, Inc.

    Elgin, Illinois · Withdrawn

  • Grace Research, LLC

    Shreveport, Louisiana · Recruiting

  • CBH Health LLC, dba CenExcel Gaithersburg

    Gaithersburg, Maryland · Recruiting

  • Khan Revive Research Institute

    Rochester Hills, Michigan · Withdrawn

  • Tekton Research, LLC

    St Louis, Missouri · Recruiting

  • Alivation Research, LLC

    Lincoln, Nebraska · Withdrawn

  • Advanced Memory Research Institute of New Jersey

    Marlton, New Jersey · Recruiting

  • Dent Neurologic Institute

    Amherst, New York · Withdrawn

  • Finger Lakes Clinical Research

    Rochester, New York · Withdrawn

  • SUNY Upstate Medical University

    Syracuse, New York · Recruiting

  • Regional Neurological Associates

    The Bronx, New York · Withdrawn

Showing 40 of 155 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.